Brii Biosciences Limited
HKEX:2137.HK
0.93 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Current Assets: | |||||||||||||||
| Cash & Cash Equivalents
| 489.65 | 489.65 | 487.494 | 487.494 | 1,190.572 | 1,190.572 | 2,966.195 | 2,966.195 | 2,855.093 | 2,855.093 | 1,444.816 | 1,444.816 | 1,034.965 | 1,034.965 | -880.359 |
| Short Term Investments
| 2,171.011 | 2,171.011 | 2,251.426 | 2,251.426 | 1,806.812 | 1,806.812 | 253.276 | 253.276 | 499.647 | 499.647 | 0 | 0 | 20 | 20 | 1,760.718 |
| Cash and Short Term Investments
| 2,660.661 | 2,660.661 | 2,738.92 | 2,738.92 | 2,997.384 | 2,997.384 | 3,219.471 | 3,219.471 | 3,354.74 | 3,354.74 | 1,444.816 | 1,444.816 | 1,054.965 | 1,054.965 | 880.359 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 122.117 | 122.117 | 109.396 | 109.396 | 79.515 | 79.515 | 73.505 | 73.505 | 59.201 | 59.201 | 44.312 | 44.312 | 37.877 | 37.877 | 0 |
| Total Current Assets
| 2,782.778 | 2,782.778 | 2,848.316 | 2,848.316 | 3,076.899 | 3,076.899 | 3,292.976 | 3,292.976 | 3,413.941 | 3,413.941 | 1,489.128 | 1,489.128 | 1,092.842 | 1,092.842 | 880.359 |
| Non-Current Assets: | |||||||||||||||
| Property, Plant & Equipment, Net
| 5.609 | 5.609 | 12.566 | 12.566 | 19.522 | 19.522 | 26.479 | 26.479 | 33.435 | 33.435 | 42.086 | 42.086 | 43.919 | 43.919 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 267.42 | 267.42 | 145.12 | 145.12 | 146.887 | 146.887 | 8.148 | 8.148 | 9.506 | 9.506 | 10.864 | 10.864 | 12.222 | 12.222 | 0 |
| Goodwill and Intangible Assets
| 267.42 | 267.42 | 145.12 | 145.12 | 146.887 | 146.887 | 8.148 | 8.148 | 9.506 | 9.506 | 10.864 | 10.864 | 12.222 | 12.222 | 0 |
| Long Term Investments
| 142.444 | 142.444 | -2,061.344 | 190.082 | -1,660.784 | 146.028 | -111.853 | 141.423 | -347.616 | 152.031 | 124.286 | 124.286 | 96.547 | 116.547 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 1,660.784 | 0 | 0 | 0 | 0 | 0 | -124.286 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 2,253.69 | 2.264 | 148.541 | 2.513 | 256.062 | 2.786 | 502.433 | 2.786 | 127.316 | 3.03 | 22.414 | 2.414 | -880.359 |
| Total Non-Current Assets
| 415.473 | 415.473 | 350.032 | 350.032 | 314.95 | 314.95 | 178.836 | 178.836 | 197.758 | 197.758 | 180.266 | 180.266 | 175.102 | 175.102 | -880.359 |
| Total Assets
| 3,198.251 | 3,198.251 | 3,198.348 | 3,198.348 | 3,391.849 | 3,391.849 | 3,471.812 | 3,471.812 | 3,611.699 | 3,611.699 | 1,669.394 | 1,669.394 | 1,267.944 | 1,267.944 | 0 |
| Liabilities & Equity: | |||||||||||||||
| Current Liabilities: | |||||||||||||||
| Account Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short Term Debt
| 3.156 | 0 | 7.998 | 0 | 9.5 | 0 | 9.267 | 0 | 8.969 | 0 | 9.247 | 0 | 8.021 | 0 | 0 |
| Tax Payables
| 2.011 | 0 | 1.307 | 0 | 1.861 | 0 | 1.284 | 0 | 1.653 | 0 | 1.175 | 0 | 1.019 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 122.713 | 125.869 | 103.584 | 111.582 | 219.613 | 229.113 | 299.081 | 308.348 | 271.744 | 280.713 | 143.99 | 153.237 | 567.214 | 575.235 | 0 |
| Total Current Liabilities
| 125.869 | 125.869 | 111.582 | 111.582 | 229.113 | 229.113 | 308.348 | 308.348 | 280.713 | 280.713 | 153.237 | 153.237 | 575.235 | 575.235 | 0 |
| Non-Current Liabilities: | |||||||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 3.156 | 3.156 | 8.204 | 8.204 | 12.647 | 12.647 | 18.165 | 6,143.341 | 20.306 | 2,423.328 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 2.083 | 0 | 4.583 | 0 | 7.083 | 0 | 9.583 | 0 | 12.083 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | -2.083 | 0 | -4.583 | 0 | -7.083 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 2.083 | 2.083 | 4.583 | 4.583 | 7.083 | 7.083 | 6,125.176 | 9.583 | 2,403.022 | 12.083 | 0 |
| Total Non-Current Liabilities
| 0 | 0 | 0 | 0 | 5.239 | 5.239 | 12.787 | 12.787 | 19.73 | 19.73 | 6,152.924 | 6,152.924 | 2,435.411 | 2,435.411 | 0 |
| Total Liabilities
| 125.869 | 125.869 | 111.582 | 111.582 | 234.352 | 234.352 | 321.135 | 321.135 | 300.443 | 300.443 | 6,306.161 | 6,306.161 | 3,010.646 | 3,010.646 | 0 |
| Equity: | |||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,974.185 | 0 | 4,711.555 | 0 | 1,812.628 | 0 | 0 |
| Common Stock
| 0.024 | 0.024 | 0.024 | 0.024 | 0.024 | 0.024 | 0.023 | 0.023 | 0.023 | 0.023 | 0.007 | 0.007 | 0.007 | 0.007 | 0 |
| Retained Earnings
| -6,697.039 | -6,697.039 | -6,712.127 | -6,712.127 | -6,522.21 | -6,522.21 | -6,385.485 | -6,385.485 | -6,037.898 | -6,037.898 | -4,827.226 | -4,827.226 | -1,874.049 | -1,874.049 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 3,119.016 | 439.277 | 487.53 | 487.53 | 364.687 | 364.687 | 257.037 | 257.037 | 63.713 | 63.713 | 115.671 | 115.671 | 61.421 | 61.421 | -612.761 |
| Other Total Stockholders Equity
| 6,697.039 | 9,376.778 | 9,355.365 | 9,355.365 | 9,352.113 | 9,352.113 | 9,328.777 | 9,328.777 | 3,342.881 | 9,317.066 | -4,631.959 | 79.596 | -1,738.296 | 74.332 | 0 |
| Total Shareholders Equity
| 3,119.04 | 3,119.04 | 3,130.792 | 3,130.792 | 3,194.614 | 3,194.614 | 3,200.352 | 3,200.352 | 3,342.904 | 3,342.904 | -4,631.952 | -4,631.952 | -1,738.289 | -1,738.289 | -612.761 |
| Total Equity
| 3,072.382 | 3,072.382 | 3,086.766 | 3,086.766 | 3,157.497 | 3,157.497 | 3,150.677 | 3,150.677 | 3,311.256 | 3,311.256 | -4,636.767 | -4,636.767 | -1,742.702 | -1,742.702 | -612.761 |
| Total Liabilities & Shareholders Equity
| 3,198.251 | 3,198.251 | 3,198.348 | 3,198.348 | 3,391.849 | 3,391.849 | 3,471.812 | 3,471.812 | 3,611.699 | 3,611.699 | 1,669.394 | 1,669.394 | 1,267.944 | 1,267.944 | -612.761 |